1,805
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Influence of blood pressure variations during hemodialysis on the prognosis of dialysis patients

, , , , , & show all
Article: 2236336 | Received 23 Mar 2023, Accepted 06 Jul 2023, Published online: 28 Jul 2023

References

  • Daratha KB, Short RA, Corbett CF, Ring ME, Alicic R, Choka R, Tuttle KR. Risks of subsequent hospitalization and death in patients with kidney disease. Clin J Am Soc Nephrol. 2012;7(3):409–6. doi:10.2215/CJN.05070511.
  • Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. An overview of regular dialysis treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2015;19(6):540–74. doi:10.1111/1744-9987.12378.
  • Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54(2):561–69. doi:10.1046/j.1523-1755.1998.00005.x.
  • Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LYC, Young EW. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507–17. doi:10.1016/S0272-6386(99)70188-5.
  • Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41(5):1286–91. doi:10.1038/ki.1992.191.
  • K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–153. doi:10.1053/j.ajkd.2005.01.019.
  • Schömig M, Eisenhardt A, Ritz E. Controversy on optimal blood pressure on haemodialysis: Normotensive blood pressure values are essential for survival. Nephrol Dial Transplant. 2001;16(3):469–74. doi:10.1093/ndt/16.3.469.
  • Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66(3):1212–20. doi:10.1111/j.1523-1755.2004.00812.x.
  • Hanafusa N, Abe M, Joki N, Hoshino J, Wada A, Kikuchi K, Goto S, Ogawa T, Kanad E, Taniguchi M. Current status of chronic dialysis therapy in Japan. Nihon Toseki Igakkai Zasshi. 2022;55:665–723.
  • Hiyamuta H, Tanaka S, Taniguchi M, Tokumoto M, Fujisaki K, Nakano T, Tsuruya K, Kitazono T. The incidence and associated factors of sudden death in patients on hemodialysis: 10-Year outcome of the Q-Cohort Study. J Atheroscler Thromb. 2020;27(4):306–18. doi:10.5551/jat.49833.
  • Georgianos PI, Agarwal R. Blood pressure and mortality in long-term hemodialysis—time to move forward. Am J Hypertens. 2016;30:211–22. doi:10.1093/ajh/hpw114.
  • Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270–77. doi:10.1097/01.ASN.0000100127.54107.57.
  • Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: Differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388:294–306. doi:10.1016/S0140-6736(16)30448-2.
  • Sumida K, Yamagata K, Iseki K, Tsubakihara Y. Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients. Nephrol Dial Transplant. 2016;31:298–305. doi:10.1093/ndt/gfv402.
  • Kopple JD. Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr. 1999;129(1):S247–S51. doi:10.1093/jn/129.1.247S.
  • Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–81. doi:10.1046/j.1523-1755.2000.00945.x.
  • Hörl MP, Hörl WH. Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis. 2002;39(2):227–44. doi:10.1053/ajkd.2002.30542.
  • Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938–42. doi:10.1161/hy1001.096358.
  • Agarwal R. Hypertension and survival in chronic hemodialysis patients—Past lessons and future opportunities. Kidney Int. 2005;67(1):1–13. doi:10.1111/j.1523-1755.2005.00050.x.
  • Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis. 2006;48(4):606–15. doi:10.1053/j.ajkd.2006.07.005.
  • Tsuruya K, Kanda E, Nomura T, Iseki K, Hirakata H. Postdialysis blood pressure is a better predictor of mortality than predialysis blood pressure in Japanese hemodialysis patients: The Japan dialysis outcomes and practice patterns study. Hypertens Res. 2020;43(8):791–97. doi:10.1038/s41440-020-0425-1.
  • Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: Systematic review and meta-analysis. Hypertension. 2009;53(5):860–66. doi:10.1161/HYPERTENSIONAHA.108.128116.
  • Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar N-O. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014;9(12):2124–32. doi:10.2215/CJN.02680314.
  • Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, Toto R, Himmelfarb J, Winchester JF, Stivelman J, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int. 2007;71(5):454–61. doi:10.1038/sj.ki.5002077.
  • Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M, et al. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease. Kidney Int. 2016;90(6):1312–20. doi:10.1016/j.kint.2016.06.028.
  • Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, Jardine MJ. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63(6):968–78. doi:10.1053/j.ajkd.2014.01.435.
  • Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69(2):406–141. doi:10.1038/sj.ki.5000081.
  • Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension. 2005;45(2):240–45. doi:10.1161/01.HYP.0000152079.04553.2c.
  • Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, Zoccali C. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68(3):1294–302. doi:10.1111/j.1523-1755.2005.00527.x.
  • Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, Tabei K, Joki N, Hase H, Nishimura M, et al. Japanese society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial. 2012;16(5):393–99. doi:10.1111/j.1744-9987.2012.01088.x.